arrow
S

Stefano Masi

University of Pisa
H指数:49
被引数:8,826

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Retrospective, Observational Study of Adherence, Persistence and Clinical Outcomes with Perindopril-Based Single-Pill or Free-Pill Antihypertensive Treatments in Italy

一项回顾性、观察性研究:意大利人群中培哚普利为基础的单片复方制剂或自由联合降压治疗的依从性、持续性和临床结局

2026-08-260
OA
From Environmental Evidence to Biomarker Selection: A Structured Decision-Support Process for Human Biomonitoring Studies in Contaminated Sites

从环境证据到生物标志物选择:受污染场地人体生物监测研究的结构化决策支持过程

Toxics
IF4.1
2026-08-190
OA
Heart failure with reduced ejection fraction in Sweden: patient adherence and persistence to quadruple pharmacotherapy prescription

瑞典射血分数降低的心力衰竭患者四联药物治疗方案的使用情况:从处方开具到患者依从性和持续性

2026-04-011
OA
Targeting the Epigenetic Remodeler GCN5 Prevents Vascular Oxidative Stress and Endothelial Dysfunction in Obesity: Insights in Patients with Cardiometabolic Disease

靶向表观遗传重塑因子GCN5可预防肥胖中的血管氧化应激和内皮功能障碍:来自心血管代谢疾病患者的见解

2025-09-080
OAAI
Expert Consensus on the Primary Aldosteronism Severity Classification and its strategic application in indicating adrenal venous sampling

村上正、ナルセ、小林英等。原发性醛固酮增多症严重程度分类的专家共识及其在肾上腺静脉采血指征中的战略应用。欧洲内分泌学杂志2025;193:85-96。

2025-07-018
OA
Triglyceride-glucose index threshold for cardiovascular mortality in hypertensive individuals - URRAH project

高血压个体中心血管死亡率的甘油三酯-葡萄糖指数阈值 - URRAH项目

2025-06-290
OAAI
Refining the link between obesity and heart failure: insights from GLP-1 receptor agonist trials and studies adopting direct adiposity measures

优化肥胖与心力衰竭之间的关联:来自GLP-1受体激动剂试验及采用直接体脂测量方法研究的见解

2025-05-220
OA
THE ASSOCIATION BETWEEN INTRAVENTRICULAR HAEMODYNAMIC FORCES, TRADITIONAL ECHOCARDIOGRAPHIC PARAMETERS AND VENTRICULAR-ARTERIAL COUPLING IN PATIENTS AT HIGH RISK FOR HEART FAILURE

心室内血流动力学力、传统超声心动图参数与心室-动脉耦联在心力衰竭高风险患者中的关联

2025-05-010
PRE
Targeting SETD7 Rescues Diabetes-Induced Impairment of Angiogenic Response by Transcriptional Repression of Semaphorin-3G

靶向SETD7通过转录抑制Semaphorin-3G,挽救糖尿病诱导的促血管生成反应损伤

2025-02-271
PRE